HomeCompareNPTSF vs MRK

NPTSF vs MRK: Dividend Comparison 2026

NPTSF yields 90.09% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NPTSF wins by $2.52M in total portfolio value
10 years
NPTSF
NPTSF
● Live price
90.09%
Share price
$2.22
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.58M
Annual income
$809,089.52
Full NPTSF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NPTSF vs MRK

📍 NPTSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNPTSFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NPTSF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NPTSF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NPTSF
Annual income on $10K today (after 15% tax)
$7,657.66/yr
After 10yr DRIP, annual income (after tax)
$687,726.09/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, NPTSF beats the other by $679,397.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NPTSF + MRK for your $10,000?

NPTSF: 50%MRK: 50%
100% MRK50/50100% NPTSF
Portfolio after 10yr
$1.32M
Annual income
$409,443.83/yr
Blended yield
31.11%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NPTSF
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NPTSF buys
0
MRK buys
0
No recent congressional trades found for NPTSF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNPTSFMRK
Forward yield90.09%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$2.58M$56.8K
Annual income after 10y$809,089.52$9,798.13
Total dividends collected$2.27M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NPTSF vs MRK ($10,000, DRIP)

YearNPTSF PortfolioNPTSF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$19,709$9,009.01$11,206$366.19+$8.5KNPTSF
2$37,683$16,594.27$12,650$502.35+$25.0KNPTSF
3$69,973$29,651.99$14,407$694.19+$55.6KNPTSF
4$126,329$51,458.17$16,585$967.82+$109.7KNPTSF
5$221,997$86,825.00$19,342$1,363.89+$202.7KNPTSF
6$380,132$142,595.30$22,913$1,947.19+$357.2KNPTSF
7$634,938$228,196.44$27,662$2,823.89+$607.3KNPTSF
8$1,035,606$356,222.82$34,159$4,173.35+$1.00MNPTSF
9$1,651,101$543,002.02$43,337$6,308.80+$1.61MNPTSF
10$2,575,767$809,089.52$56,776$9,798.13+$2.52MNPTSF

NPTSF vs MRK: Complete Analysis 2026

NPTSFStock

Napatech A/S provides reconfigurable computing solutions for the network management and cybersecurity applications worldwide. The company offers Link Capture Software that enables packet capture with nanosecond timestamping and replay with precise inter-frame gap control; Link Inline Software, which provides a processing architecture that offloads and accelerates flow aware application data planes; Link Virtualization Software that offloads and accelerates the Open vSwitch data plane to enhance CPU efficiency and network performance; and Link Programmable, which enables end users and OEMs to deploy FPGA computation solutions on SmartNIC platform, as well as Link-Assure professional services. It also provides solutions for telecom operators, cloud and data center service providers, and infrastructure and defense, as well as financial services, cyber security, network management, and virtualization. The company was incorporated in 2003 and is headquartered in Copenhagen, Denmark.

Full NPTSF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NPTSF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NPTSF vs SCHDNPTSF vs JEPINPTSF vs ONPTSF vs KONPTSF vs MAINNPTSF vs JNJNPTSF vs ABBVNPTSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.